Synthetic bio-technology to boost green chemicals production by Guy Hélin

The start-up focusing on applications of micro-organisms to industry, using the tools developed initially to decode the human genes in labs.

Key Issue for industrial biotech companies is gene containment which requires a gene firewall which Syngulon developed based on bacteriocins. Syngulon owns a fully patented technology enabling gene containment and genetic shielding for industrial biotech . Syngulon are looking for industrial partners to join the PARAGEN project financed by the Belgium Wallonie Region.

Advertisements